Total medical devices industry deals worth $7.09bn were announced globally for March 2021, with the $1.07bn asset transaction with Lumenis being the sector’s biggest investment, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 60.4% over the previous month of $4.42bn and a drop of 27.6% when compared with the last 12-month average of $9.79bn.
In terms of number of deals, the sector saw a drop of 4.82% with 158 deals in March 2021 when compared to the last 12-month average of 166 deals.
In value terms, North America led the activity with deals worth $4.89bn in March 2021.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataMedical Devices industry deals in March 2021: Top deals
The top five deals accounted for 50.2% of the overall value during March 2021.
The combined value of the top five deals stood at $3.56bn, against the overall value of $7.09bn recorded for the month.
The top five medical devices industry deals of March 2021 tracked by GlobalData were:
1) Boston Scientific’s $1.07bn asset transaction with Lumenis
2) The $1bn private equity deal with Cardinal Health by Hellman & Friedman
3) Agilent Technologies’ $695m acquisition of Resolution Bioscience
4) The $475m acquisition deal of Northfield Medical by Agiliti
5) Bio Techne’s acquisition deal with Asuragen for $320m.
